The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
about
Nicotinic receptor-mediated effects on appetite and food intakeLeptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studiesType 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei.Ventromedial hypothalamus-specific Ptpn1 deletion exacerbates diet-induced obesity in female mice.Adipocyte apoptosis in the regulation of body fat mass by leptin.Role of leptin in glucose metabolism in type 2 diabetes.Sixteen years and counting: an update on leptin in energy balanceReduction of high-fat diet-induced obesity after chronic administration of brain-derived neurotrophic factor in the hypothalamic ventromedial nucleusSerum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey.Leptin and its role in hippocampal synaptic plasticityElectroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPARγ and Leptin Receptor in CNSLeptin: a diverse regulator of neuronal functionEffects of leptin on rat ventromedial hypothalamic neuronsNeuronal control of energy homeostasisLeptin signaling in brain: A link between nutrition and cognition?Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice.Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat.Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus.Leptin enhances NR2B-mediated N-methyl-D-aspartate responses via a mitogen-activated protein kinase-dependent process in cerebellar granule cells.Leptin promotes rapid dynamic changes in hippocampal dendritic morphology.Daily CCK injection enhances reduction of body weight by chronic intracerebroventricular leptin infusion.Leptin inhibits epileptiform-like activity in rat hippocampal neurones via PI 3-kinase-driven activation of BK channels.Important role of ventromedial hypothalamic carnitine palmitoyltransferase-1a in the control of food intake.Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance.CNS Targets of Adipokines.Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake.Efficacy and safety of a dieckol-rich extract (AG-dieckol) of brown algae, Ecklonia cava, in pre-diabetic individuals: a double-blind, randomized, placebo-controlled clinical trial.Intracerebroventricular administration of leptin-induced apoptosis in the rat small intestinal mucosa.Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus.Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
P2860
Q24646751-E81E491E-39D6-48FF-87CF-D042E21067CBQ24650977-475FC87E-D522-42C8-9B71-F713C82BC177Q30423107-7F16436B-7457-4EB0-9996-6CB2BDA0B7B0Q30433300-AE74249D-6F2E-467D-94C2-EA44086A18EEQ33996305-126E9195-2115-4C2F-A969-CD1BB11A50D2Q34117513-76097405-E911-45D2-980D-A4C987EBACB8Q34434716-79DBFF92-AB8F-4A9B-96AD-019C6C8779A3Q34669326-7EF26088-9129-4EDC-B4BC-61614132D63AQ35015746-EED97F78-57B7-4A67-AF0E-01C3161E9627Q35302146-6859AAB9-EC70-4E3C-9E55-ECD010094E21Q35511113-ED772296-7A71-471F-B5B0-EC7E658D826DQ36470247-90A141B2-ACA2-4479-8BDA-966D15BA7C66Q36556337-5B097410-F146-4577-9FBB-FC671E46778CQ36640453-0A37326D-E621-429E-8D25-5E9105BA2A29Q36972744-D5269B67-531C-4E79-9E51-3AD8C4B4EEAAQ37025375-4A188F71-7CD7-4545-B630-9BDA42CF30CBQ37161453-6BC4D61D-10A5-419D-83BF-B22EB068BF08Q37357483-BC2AE898-335C-4B2E-8BA7-4478C1FAB034Q38309530-D0036813-B1AC-4A6C-AC18-BA6988304ACBQ38325306-79357DC0-95C1-40ED-B147-2482A4EDED31Q38327895-37C4E585-3BCE-4A60-B78C-E1DD3F04E593Q38703317-2A11F9F0-B6A3-4289-AD63-44B6970685E4Q41352832-89D08D18-1D65-4D61-9309-0E39D61FDBB7Q43963479-20AE3A24-5F7F-4989-9A43-BA8D3511B350Q44249848-60CACB61-2A1C-431F-B902-5861F342EFEAQ45051883-13BD7359-7DA1-4420-9B70-779116FB573CQ47293432-2EB3F46B-19E3-4241-9D89-A10B03C6C08AQ47978333-6B8FCCB6-760B-4560-B56F-98154939C791Q48144460-41EA350F-018D-42CE-AE27-F5D95F2AFA0AQ51062713-078F92B0-8DE3-4BFD-B0BC-2B1E12C21873Q51533378-6CE26C90-E8C6-4959-9FA4-9C0F8F826B6DQ51556166-356891E7-2422-4777-AF70-D163619BDDB3Q51558091-F35B95CF-04F1-4729-A1A1-C264F3CAF488
P2860
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
@en
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
@nl
type
label
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
@en
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
@nl
prefLabel
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
@en
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
@nl
P2093
P356
P1433
P1476
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus
@en
P2093
M B Medwick
R S Sherwin
P304
P356
10.2337/DIAB.46.1.150
P407
P577
1997-01-01T00:00:00Z